Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes
Arthritis Care & Research · 2023-10 · 75 (10) · 2199-2206
DOI: 10.1002/acr.25116 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Arthritis Care & Research, online erschienen am 17.04.2023. Verfasst von Anthony Dolomisiewicz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha. Hauptthemen laut MEDLINE: Rheumatic Diseases, Arthritis, Rheumatoid. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSRD VA, RRD VA, NIGMS NIH HHS.
Abstract (Originalsprache)
Objective
To update and validate the Rheumatic Disease Comorbidity Index (RDCI) utilizing International Classification of Diseases, Tenth Revision, Clinical Modification (ICD‐10‐CM) codes.
Methods
We defined ICD‐9‐CM (n = 1,068) and ICD‐10‐CM (n = 1,425) era cohorts (n = 862 in both) spanning the ICD‐9‐CM to ICD‐10‐CM transition in a multicenter, prospective rheumatoid arthritis registry. Information regarding comorbidities was collected from linked administrative data over 2‐year assessment periods. An ICD‐10‐CM code list was generated from crosswalks and clinical expertise. ICD‐9– and ICD‐10–derived RDCI scores were compared using intraclass correlation coefficients (ICC). The predictive ability of the RDCI for functional status and death during follow‐up was assessed using multivariable regression models and goodness‐of‐fit statistics (Akaike's information criterion [AIC] and quasi information criterion [QIC]) in both cohorts.
Results
Mean ± SD RDCI scores were 2.93 ± 1.72 in the ICD‐9‐CM cohort and 2.92 ± 1.74 in the ICD‐10‐CM cohort. RDCI scores had substantial agreement in individuals who were in both cohorts (ICC 0.71 [95% confidence interval 0.68–0.74]). Prevalence of comorbidities was similar between cohorts with absolute differences
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.
- University of Nebraska Medical Center, Omaha.
- Salt Lake City VA and University of Utah, Salt Lake City.
- Corporal Michael J. Crescenz VA and University of Pennsylvania, Philadelphia.
- University of Nebraska Medical Center, Omaha, and FORWARD, The National Data Bank for Rheumatic Diseases, Wichita, Kansas.
ORCID-Profile: Anthony Dolomisiewicz, Grant W Cannon, Brian Sauer, Joshua F Baker, Ted R Mikuls, Kaleb Michaud, Bryant R England
Förderung
- CSRD VA
- RRD VA
- NIGMS NIH HHS
- BLRD VA
- National Institute of General Medical Sciences
- Rheumatology Research Foundation
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
Zitieren
APA
Dolomisiewicz, A., Ali, H., Roul, P., Yang, Y., Cannon, G. W., Sauer, B., Baker, J. F., Mikuls, T. R., Michaud, K., & England, B. R. (2023). Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes. Arthritis Care & Research, 75(10), 2199-2206. https://doi.org/10.1002/acr.25116
Vancouver
Dolomisiewicz A, Ali H, Roul P, Yang Y, Cannon GW, Sauer B, et al. Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes. Arthritis Care & Research. 2023;75(10):2199-2206. doi:10.1002/acr.25116
BibTeX
@article{Dolomisiewicz2023,
author = {Dolomisiewicz, Anthony and Ali, Hanifah and Roul, Punyasha and Yang, Yangyuna and Cannon, Grant W and Sauer, Brian and Baker, Joshua F and Mikuls, Ted R and Michaud, Kaleb and England, Bryant R},
title = {Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes},
journal = {Arthritis Care & Research},
year = {2023},
volume = {75},
number = {10},
pages = {2199--2206},
doi = {10.1002/acr.25116}
}
EUVIMED